CH de Chateauroux
About CH de Chateauroux
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at CH de Chateauroux
During the past decade, CH de Chateauroux conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Comparison of SCH 56592 and Fluconazole in the Treatment of Oropharyngeal Candidiasis (OPC) in HIV-Positive Patients
Completed
500
Lymph Node Radiation Therapy in Patients With Stage I, Stage II, or Stage III Breast Cancer That Has Been Surgically Removed
1996-07-01
Unknown status
4,000
Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count
1997-11-01
Completed
859
Interleukin-2 Plus Histamine Dihydrochloride in Treating Patients With Acute Myeloid Leukemia
1998-07-01
2011-08-01
Completed
360
Radiation Therapy in Patients With Limited-Stage Small Cell Lung Cancer in Complete Remission
1999-09-01
2005-12-01
Completed
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
1999-10-01
2013-04-01
Completed
460
Effectiveness and Safety of Two Forms of Stavudine in HIV-Infected Patients
2000-06-01
2002-04-01
Completed
730
Gemcitabine With/Out Erlotinib in Unresectable Locally Advanced/Metastatic Pancreatic Cancer
2001-10-29
2009-02-10
Completed
569
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "CH de Chateauroux" #1 sponsor was "University Hospital, Angers" with 3 trials, followed by "ARCAGY/ GINECO GROUP" with 1 trials
sponsored, "Biotronik France" with 1 trials sponsored, "Centre Hospitalier Departemental Vendee" with 1 trials sponsored and "Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company"
with 1 trials sponsored. Other sponsors include 2 different institutions and
companies that sponsored additional 12 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "CH de Chateauroux"
#1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Biotronik SE & Co. KG" with 1 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator, "Fund for Clinical Cardiovascular Research at LRD" with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 7 trials.
Clinical Trials Conditions at CH de Chateauroux
According to Clinical.Site data, the most researched conditions in "CH de Chateauroux" are
"Acute Coronary Syndrome" (2 trials), "Chronic Hepatitis C" (2 trials), "Quality of Health Care" (2 trials), "Atherosclerotic Cardiovascular Disease" (1 trials) and "Atrial Fibrillation" (1 trials). Many other conditions were trialed in "CH de Chateauroux" in a lesser frequency.
Clinical Trials Intervention Types at CH de Chateauroux
Most popular intervention types in "CH de Chateauroux" are "Drug" (5 trials), "Other" (3 trials), "Procedure" (2 trials), "Behavioral" (1 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Anti-EGFR agent (cetuximab +/- irinotecan or panitumumab)" (1 trials), "Bivalirudin" (1 trials), "Clopidogrel" (1 trials), "Computer-Assisted diagnostic Decision Support" (1 trials) and "Coronary angiography" (1 trials). Other intervention names were less common.
Clinical Trials Genders at CH de Chateauroux
The vast majority of trials in "CH de Chateauroux" are
13 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at CH de Chateauroux
Currently, there are NaN active trials in "CH de Chateauroux".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 10 completed trials in CH de Chateauroux,
1 suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in CH de Chateauroux, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 3 trials that are defined as “Not Applicable".